InflaRx (IFRX) Raw Materials (2023 - 2025)
InflaRx (IFRX) posted Raw Materials of $92922.6 for Q2 2025, up 5.93% sequentially from $87717.8 in Q4 2024, and down 37.66% YoY from $149056.3 in Q2 2024.
InflaRx (IFRX) Raw Materials (2023 - 2025) Analysis & Trends
InflaRx has reported Raw Materials for 3 years, with the latest figure at $92922.6 in Q2 2025.
- Quarterly Raw Materials fell 37.66% year-over-year to $92922.6 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $92922.6 (down 37.66% YoY) and the FY2024 annual result came in at $88845.9, down 80.61% from the prior year.
- Raw Materials climbed to $92922.6 in Q2 2025 per IFRX's latest filing, from $87717.8 in the prior quarter.
- Over five years, Raw Materials peaked at $1214.0 billion in Q3 2023 and troughed at $87717.8 in Q4 2024.
- A 3-year average of $242.8 billion and a median of $149056.3 in 2024 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2024 and 2025: Raw Materials plunged 80.75% in 2024, then plunged 37.66% in 2025.
- Over 3 years, Raw Materials stood at $455725.1 in 2023, then slumped by 80.75% to $87717.8 in 2024, then rose by 5.93% to $92922.6 in 2025.
- According to Business Quant data, Raw Materials over the past three periods registered $92922.6, $87717.8, and $149056.3 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 92,922.57 |
| Dec 31, 2024 | 87,717.79 |
| Jun 30, 2024 | 149,056.32 |
| Dec 31, 2023 | 455,725.11 |
| Sep 30, 2023 | 1,214.04 Bn |